Press Releases

Rhenovia Pharma, a biotechnology company created in 2007, today announces it has had its position confirmed as world leader in the field of biosimulation for research into drugs for treating diseases of the central nervous system. ...

Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a randomized Phase 2 study of its lead candidate, CRLX101, in patients with extensive-stage small cell lung cancer...

Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) recommended that clinical data included in a new drug application (NDA) provide substantial and convincing evidence to support the approval of...

Regional Cancer Care Associates (RCCA), New Jersey’s largest oncology physician network and one of the largest in the nation, is pleased to announce that three practices have joined its growing network, which now includes 92 cancer care specialists...

Direct Flow Medical, Inc., a transcatheter heart valve innovator focused on improving patient outcomes, announced that it has received CE Mark (Conformité Européenne) for its distinctive transcatheter aortic heart valve with a metal-free frame and low-profile transfemoral delivery...

Domain Therapeutics S.A. announced today that Domain Therapeutics grants Prexton Therapeutics (Geneva, Switzerland) an exclusive option to license and develop metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting Parkinson’s disease. The chemical series...

Almac is pleased to announce the successful completion of the Knowledge Transfer Partnership (KTP) with Queens University Belfast, to develop, improve and embed bioprocesses in order to facilitate the delivery of novel products for its biocatalysis business. ...